Patent · US Active

Dispersible formulations of n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benazmide and uses thereof

US12090128B2 · kind B2 · utility

1Cited by

8References

23Claims

0Family size

Assignee

SpringWorks Therapeutics, Inc. · US

Inventors

Kristin Patterson · Stamford, US
Jiping Liu · Tuji, CN

Key dates

Filing date	Jan 31, 2024
Grant date	Sep 17, 2024
Priority date	—
Expiry date	Jan 31, 2044

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/2072
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to dispersible pharmaceutical compositions comprising N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide, and, optionally, a pharmaceutically acceptable carrier.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.